Advanced Enzyme Technologies Limited (ADVENZYMES)
Valuation Rating
Score: 22/100
Valuation Overview
| P/E Ratio | 24.464586 |
| P/B Ratio | 2.4151592 |
| Dividend Yield | 177.0% |
| Current Price | ₹290.15 |
| DCF Value | ₹197.40274704582555 |
| Upside Potential | N/A% |
Intrinsic Values
| Current Price | ₹290.15 |
| DCF Value | ₹197.40274704582555 |
| Graham Value | ₹215.29115164494402 |
| DDM Value | ₹93.48913952491725 |
| Earnings Value | ₹227.38294003335636 |
| Average Value | ₹174.16134144757592 |
Growth Confidence
| Revenue Growth | 0% |
| Earnings Growth | 0% |
| Revenue Confidence | 0% |
| Earnings Confidence | 0% |
| Margin Confidence | 0% |
| Overall Growth Confidence | 0% |
Growth Metrics
| EPS Growth | -10.2% |
| Revenue Growth | 5.1% |
| Market Cap | ₹3246.23 Cr |
Valuation Analysis Score: 22/100
Undervaluation Score: 22/100
Valuation Score: 18/30
Growth Score: 4/30
Intrinsic Value Score: 0/40
Growth Score: 4/30
Intrinsic Value Score: 0/40
Key Analysis Points:
- Moderate P/E ratio below 25
- Adequate P/B ratio below 3
- Excellent operating margins above 20%
- Moderate growth confidence score above 40%
Recommendation
Caution - Stock may be overvalued, detailed analysis recommended
Detailed Metrics
Current Price: ₹290.15
Operating Margins: 27.4%
Revenue Growth: 0.0%
Earnings Growth: 0.0%
Growth Confidence: 50.9%
Risk Assessment Guide
- Score 80-100: Significantly undervalued with strong fundamentals
- Score 60-79: Moderately undervalued with good potential
- Score 40-59: Fairly valued with balanced metrics
- Score Below 40: Potentially overvalued, exercise caution
Last Updated: 2025-04-16 19:00:31